Canada markets close in 3 hours 53 minutes

ABVC BioPharma, Inc. (ABVC)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
1.0700-0.0400 (-3.60%)
As of 12:00PM EDT. Market open.
Currency in USD

Valuation Measures4

Market Cap (intraday) 11.72M
Enterprise Value 13.86M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)31.57
Price/Book (mrq)1.40
Enterprise Value/Revenue 90.93
Enterprise Value/EBITDA -1.70

Trading Information

Stock Price History

Beta (5Y Monthly) 0.75
52-Week Change 3-85.77%
S&P500 52-Week Change 325.59%
52 Week High 38.8500
52 Week Low 30.6740
50-Day Moving Average 31.1983
200-Day Moving Average 31.3690

Share Statistics

Avg Vol (3 month) 31.16M
Avg Vol (10 day) 31.32M
Shares Outstanding 510.56M
Implied Shares Outstanding 610.56M
Float 86.8M
% Held by Insiders 126.97%
% Held by Institutions 14.12%
Shares Short (Apr 15, 2024) 4532.98k
Short Ratio (Apr 15, 2024) 40.31
Short % of Float (Apr 15, 2024) 46.91%
Short % of Shares Outstanding (Apr 15, 2024) 45.05%
Shares Short (prior month Mar 15, 2024) 4105.84k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 08, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3Jul 25, 2023

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-90,605.55%

Management Effectiveness

Return on Assets (ttm)-42.67%
Return on Equity (ttm)-191.96%

Income Statement

Revenue (ttm)152.43k
Revenue Per Share (ttm)0.04
Quarterly Revenue Growth (yoy)-99.60%
Gross Profit (ttm)N/A
EBITDA -8.19M
Net Income Avi to Common (ttm)-10.52M
Diluted EPS (ttm)-2.4300
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)139.47k
Total Cash Per Share (mrq)0.01
Total Debt (mrq)2.45M
Total Debt/Equity (mrq)30.13%
Current Ratio (mrq)0.28
Book Value Per Share (mrq)1.06

Cash Flow Statement

Operating Cash Flow (ttm)-4.24M
Levered Free Cash Flow (ttm)-2.77M